RxDoctor Payments Data

Taylor White, DO

Family Medicine · Asheville, NCNPI 1811459522

Payments from drug & device makers

$1,154in general payments, 2019–2025

Across 59 payments — averaging $19.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Viiv Healthcare Company$463
  • Gilead$238
  • Indivior Inc.$144
  • Boehringer Ingelheim$125
  • GSK$30
  • Braeburn Inc.$22
  • plus $130 from 7 others

What the payments were for

  • Food & beverage$1,154100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,154 in reported general payments places this provider in the 70th percentile of 3,444 family medicine providers in North Carolina.

See all family medicine providers in North Carolina

Medicare billing

Part B allowed, 2024
$344
Medicare patients
21
Services billed
34

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
BiktarvyBictegrav/Emtricit/Tenofov Ala233$923,616
DovatoDolutegravir Sodium/Lamivudine128$372,521
JulucaDolutegravir/Rilpivirine62$224,412
TrulicityDulaglutide57$62,062
JardianceEmpagliflozin44$54,590
OzempicSemaglutide43$45,096
OdefseyEmtricitab/Rilpiviri/Tenof Ala13$38,879
JanuviaSitagliptin Phosphate32$36,188
XareltoRivaroxaban28$24,663
VraylarCariprazine Hcl11$17,605
EliquisApixaban16$17,212
Spiriva HandihalerTiotropium Bromide16$13,492
Synjardy XrEmpagliflozin/Metformin Hcl11$12,647
Repatha SureclickEvolocumab11$6,165
SymbicortBudesonide/Formoterol Fumarate22$5,114

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
GileadBiktarvy$238$923,616233 claims
Viiv Healthcare CompanyDovato, Juluca$463$596,933190 claims
Boehringer IngelheimJardiance, Synjardy Xr$125$67,23755 claims
Johnson & JohnsonXarelto$19$24,66328 claims
AbbVieVraylar$16$17,60511 claims
GSKShingrix$30$4,04119 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 3,444 family medicine providers in North Carolina.

Other family medicine in Asheville

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →